Pre-clinical whole-body fluorescence imaging: Review of instruments, methods and applications

被引:467
作者
Leblond, Frederic [1 ]
Davis, Scott C. [1 ]
Valdes, Pablo A. [1 ]
Pogue, Brian W. [1 ,2 ]
机构
[1] Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA
[2] Dartmouth Med Sch, Dept Surg, Hanover, NH 03756 USA
基金
美国国家卫生研究院;
关键词
Fluorescence; Imaging; Tomography; Commercial; Small animal; Diagnostic; DIFFUSE OPTICAL TOMOGRAPHY; MODALITY MAGNETIC-RESONANCE; BLOOD-BRAIN-BARRIER; IN-VIVO; MOLECULAR TOMOGRAPHY; NONINVASIVE FLUORESCENT; ADJOINT SENSITIVITIES; CEREBRAL-ISCHEMIA; PROTEASE ACTIVITY; GENE-EXPRESSION;
D O I
10.1016/j.jphotobiol.2009.11.007
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Fluorescence sampling of cellular function is widely used in all aspects of biology, allowing the visualization of cellular and sub-cellular biological processes with spatial resolutions in the range from nanometers up to centimeters. Imaging Of fluorescence in vivo has become the most commonly used radiological tool in all pre-clinical work. In the last decade. full-body pre-clinical imaging systems have emerged with a wide range of utilities and niche application areas. The range of fluorescent probes that can be excited in the visible to near-infrared part of the electromagnetic spectrum continues to expand, with the most value for in vivo use being beyond the 630 nm wavelength, because the absorption of light sharply decreases. Whole-body in vivo fluorescence imaging has not yet reached a state of maturity that allows its routine use in the scope of large-scale pre-clinical studies. This is in part due to an incomplete understanding of what the actual fundamental capabilities and limitations of this imaging modality are However. progress is continuously being made in research laboratories pushing the limits of the approach to consistently improve its performance in terms of spatial resolution, sensitivity and quantification. This paper reviews this imaging technology with a particular emphasis on its potential uses and limitations, the required instrumentation, and the possible imaging geometries and applications A detailed account of the main commercially available systems is provided as well as some perspective relating to the future of the technology development. Although the vast majority of applications of in vivo small animal imaging are based on epi-illumination planar imaging, the future Success of the method relies heavily oil the design of novel imaging systems based on state-of-the-art optical technology used in conjunction with high spatial resolution structural modalities such as MRI, CT or ultrasound Published by Elsevier B V
引用
收藏
页码:77 / 94
页数:18
相关论文
共 173 条
  • [1] Osteogenesis associates with inflammation in early-stage atherosclerosis evaluated by molecular imaging in vivo
    Aikawa, Elena
    Nahrendorf, Matthias
    Figueiredo, Jose-Luiz
    Swirski, Filip K.
    Shtatland, Timur
    Kohler, Rainer H.
    Jaffer, Farouc A.
    Aikawa, Masanori
    Weissleder, Ralph
    [J]. CIRCULATION, 2007, 116 (24) : 2841 - 2850
  • [2] Spatially varying regularization based on spectrally resolved fluorescence emission in fluorescence molecular tomography
    Axelsson, Johan
    Svensson, Jenny
    Andersson-Engels, Stefan
    [J]. OPTICS EXPRESS, 2007, 15 (21) : 13574 - 13584
  • [3] In vivo diagnosis of epidermal growth factor receptor expression using molecular imaging with a cocktail of optically labeled monoclonal antibodies
    Barrett, Tristan
    Koyama, Yoshinori
    Hama, Yukihiro
    Ravizzini, Gregory
    Shin, In Soo
    Jang, Beom-Su
    Paik, Chang H.
    Urano, Yasuteru
    Choyke, Peter L.
    Kobayashi, Hisataka
    [J]. CLINICAL CANCER RESEARCH, 2007, 13 (22) : 6639 - 6648
  • [4] Seeing the wood through the trees: A review of techniques for distinguishing green fluorescent protein from endogenous autofluorescence
    Billinton, N
    Knight, AW
    [J]. ANALYTICAL BIOCHEMISTRY, 2001, 291 (02) : 175 - 197
  • [5] Whole-body fluorescence lifetime imaging of a tumor-targeted near-infrared molecular probe in mice
    Bloch, S
    Lesage, F
    McIntosh, L
    Gandjbakhche, A
    Liang, KX
    Achilefu, S
    [J]. JOURNAL OF BIOMEDICAL OPTICS, 2005, 10 (05)
  • [6] Optical imaging of the adoptive transfer of human endothelial cells in mice using anti-human CD31 monoclonal antibody
    Bogdanov, Alexei A., Jr.
    Lin, Charles P.
    Kang, Hye-Won
    [J]. PHARMACEUTICAL RESEARCH, 2007, 24 (06) : 1186 - 1192
  • [7] Time-resolved scanning system for double reflectance and transmittance fluorescence imaging of diffusive media
    Brambilla, Marco
    Spinelli, Lorenzo
    Pifferi, Antonio
    Torricelli, Alessandro
    Cubeddu, Rinaldo
    [J]. REVIEW OF SCIENTIFIC INSTRUMENTS, 2008, 79 (01)
  • [8] Optical-based molecular imaging: contrast agents and potential medical applications
    Bremer, C
    Ntziachristos, V
    Weissleder, R
    [J]. EUROPEAN RADIOLOGY, 2003, 13 (02) : 231 - 243
  • [9] Optical imaging of matrix metalloproteinase-2 activity in tumors: Feasibility study in a mouse model
    Bremer, C
    Bredow, S
    Mahmood, U
    Weissleder, R
    Tung, CH
    [J]. RADIOLOGY, 2001, 221 (02) : 523 - 529
  • [10] Biochemical and in vivo characterization of a small, membrane-permeant, caspase-activatable far-red fluorescent peptide for imaging apoptosis
    Bullok, Kristin E.
    Maxwell, Dustin
    Kesarwala, Aparna H.
    Gammon, Seth
    Prior, Julie L.
    Snow, Margaret
    Stanley, Sam
    Piwnica-Worms, David
    [J]. BIOCHEMISTRY, 2007, 46 (13) : 4055 - 4065